Randomized, Controlled, Double-Blind, Parallel Trial to Evaluate the Safety and Efficacy of TP- 03 for the Treatment of Blepharitis Due to Demodex Infestation
Latest Information Update: 06 May 2021
At a glance
- Drugs Lotilaner (Primary)
- Indications Blepharitis
- Focus Adverse reactions; Therapeutic Use
- Acronyms Europa
Most Recent Events
- 03 May 2021 According to a Tarsus Pharmaceuticals media release, positive results observed in the Europa study were used as the basis for the pivotal Phase 2b/3 Saturn-1 and Phase 3 Saturn-2 trials of TP-03 to treat Demodex blepharitis.
- 03 May 2021 Results presented in a Tarsus Pharmaceuticals Media Release.
- 03 May 2021 According to a Tarsus Pharmaceuticals media release, data presented at the virtual Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting.